What is ABBV's current stock price?

As of now, ABBV is trading at $223.32, with a daily change of -0.29%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

ABBV Stock Analysis & IQ Rating | AbbVie

ABBV ABBV Badge

AbbVie

$223.32

-$0.66 | -0.29%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$244.81

MKT CAP

$394.69B

52W Low

$164.39

VOL

$5.06M

P/E Ratio

168.5

AVG VOL

$5.99M

RSI

44.97

TREND

Downtrend

ABBV Stock IQ

Login to see AbbVie (ABBV) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

ABBV Target Price

Login to display

Strengths

ABBV Rewards

Earnings are forecast to grow

ABBV Rewards

Upgraded on attractively valued

ABBV Rewards

Trading below its fair value

ABBV Rewards

Investors confidence is positive

Technical Indicators

ABBV Technical Indicators

MACD above signal line

ABBV Price Performance

$234 (-4.56%)

$222.47 (+0.38%)

$190.83 (+17.03%)

$178.01 (+25.45%)

1year

6month

3month

1month

ABBV Risk Level

ABBV has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

ABBV Analysts Opinion

ABBV overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

ABBV Analysts Opinion

ABBV Analysts opinion is positive and also has improved from the past 3 months

ABBV Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential

95%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

88%

ABBV Street Sentiment

ABBV Street Sentiment is extremely bullish and have positive views on the near-term outlook

ABBV Performance Sentiment

Sentiments overview associated with ABBV events and the stock performance.

95%

3%

Positive

Negative

35 out of 37
events present

1 out of 37
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Login to display

Support
Price

$223.32

Resistance
Price

$215.62

Current Price Range

$236.28

Show methods +

Linked to ABBV

IQ

Close Price

Change

PFE

3.94

25.85

+0.12%

SNY

4.02

48.68

-0.37%

NVS

4.27

132.57

+0.15%

MRK

4.03

100.30

+1.30%

LLY

4.13

1027.51

+1.83%

ABBV Latest Analysis +

AbbVie Slipped Below 50-Day SMA Last Week: How to Play the Stock. AbbVie dips below its 50-day SMA but strong immunology momentum and a resilient long-term trend keep the story compelling.

Fri Dec 12, 2025

$223.32 | -0.29%

Momentum

Potential

Leading Multiple Myeloma Results Unveiled at ASH 2025: Paradigm-Shifting Data Redefines Treatment Landscape | DelveInsight. ASH Annual Meeting and Exposition leaves the oncology community buzzing over a series of late-breaking presentations that experts are calling unprecedented. Major pharmaceutical developers such as Johnson & Johnson Arcellx Gilead Bristol Myers Squibb Regeneron AbbVie CellCentric...

Thu Dec 11, 2025

$223.98 | -0.53%

Activity

Is AbbVie Stock Too Cheap to Ignore at Todays Price?.

Thu Dec 11, 2025

$223.98 | -0.53%

Potential

DISCO Pharmaceuticals Appoints Mark Manfredi as CEO and Announces Final Close of €36 Million Seed Financing. Mark Manfredi brings over two decades of international biopharmaceutical industry leadership and cancer drug discovery success to DISCOFinancing will support the development of novel surfaceome-targeted therapies for hard-to-treat tumorsCologne Germany December 11 2025 – (DISCO) today announced the appointment of seasoned biotech leader Mark Manfredi Ph.D. as Chief Executive Officer (CEO

Thu Dec 11, 2025

$223.98 | -0.53%

Activity

HSBC Upgrades AbbVie (ABBV) to Buy Raises Price Target to $265. AbbVie Inc. (NYSE:ABBV) is included among the 15 Best Stocks to Buy for the Long Term. On December 10 HSBC increased its price target on AbbVie Inc. (NYSE:ABBV) from $225 to $265 and also upgraded the stock to Buy. Previously on November 5 Piper Sandler reiterated a Buy rating on ABBV with a $289 price [….]

Thu Dec 11, 2025

$223.98 | -0.53%

Activity

Potential

Rating

HSBC Upgrades AbbVie (ABBV). Fintel reports that on December 10 2025 HSBC upgraded their outlook for AbbVie (NYSE:ABBV) from Hold to Buy. Analyst Price Forecast Suggests 11.48% Upside

Wed Dec 10, 2025

$225.18 | +0.98%

Potential

Rating

This AbbVie Analyst Turns ish. Here Are Top 5 Upgrades For Wednesday. Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes including upgrades downgrades and initiations please see our analyst ratings page.BMO Capital analyst Benjamin Mayhew upgraded ) from Market Perform to Outperform and raised the price target from $50 to $65. Andersons shares closed at $49.36 on Tuesday. See how other analysts view this stock.HSBC analyst Rajesh

Wed Dec 10, 2025

$225.18 | +0.98%

Potential

Rating

3 Top Dividend Stocks to Buy in December. Key PointsAbbVie is a Dividend King that has proven its resilience.

Tue Dec 9, 2025

$222.99 | -0.03%

Potential

OSE Immunotherapeutics Announces Strategic Amendment to AbbVies Partnership on ABBV-230 Development. OSE Immunotherapeutics Announces Strategic Amendment to AbbVie'.s Partnership on ABBV-230 Development Strategic Amendment Enhances OSE Immunotherapeutics'. Role in ABBV-230 Development While Preserving AbbVie'.s Long-Term CommitmentNANTES France December 8th 2025 – 7:30am CET - OSE Immunotherapeutics SA (SGMX: Mnemo: OSE)) today announced an amendment to its partnership agreement with

Mon Dec 8, 2025

$223.12 | -1.31%

Activity

How Strong Is AbbVies Immunology Franchise After Humiras LOE?. ABBV rebounds after Humiras LOE as soaring Skyrizi and Rinvoq sales drive a powerful immunology comeback.

Thu Dec 4, 2025

$228.71 | -0.60%

Momentum

FAQ About ABBV Stock Insights

What is ABBV current stock price?

What are ABBV stock strengths?

What is ABBV Risk Level?

What is ABBV market cap and volume?

What is ABBV current Stock IQ?

Should I buy ABBV stock right now?

Is ABBV a Strong Buy right now?

What does a 'Strong Buy' rating mean for ABBV?

What does a 'Strong Sell' rating mean for ABBV?

What factors influence ABBV's Stock IQ?

Explore our ABBV Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored ABBV Stock Strategies
Effective Risk Management

FIND US ON

Receive our ABBV Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

ABBV ABBV Badge

AbbVie

Current Price

$223.32

-$0.66 | -0.29%

52W High

$244.81

MKT CAP

$394.69B

52W Low

$164.39

VOL

$5.06M

P/E Ratio

168.5

AVG VOL

$5.99M

RSI

44.97

TREND

Downtrend

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

ABBV Rewards

Earnings are forecast to grow

ABBV Rewards

Upgraded on attractively valued

ABBV Rewards

Trading below its fair value

ABBV Rewards

Investors confidence is positive

Technical Indicators

ABBV Technical Indicators

MACD above signal line

Linked to ABBV

Symbol

IQ

Close

Change

PFE

3.94

25.85

+0.12%

SNY

4.02

48.68

-0.37%

NVS

4.27

132.57

+0.15%

MRK

4.03

100.30

+1.30%

LLY

4.13

1027.51

+1.83%

ABBV Price Performance

$234 (-4.56%)

$222.47 (+0.38%)

$190.83 (+17.03%)

$178.01 (+25.45%)

1year

6month

3month

1month

ABBV Analysts Opinion

ABBV Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

ABBV Analysts Opinion

ABBV Analysts opinion is positive and also has improved from the past 3 months

ABBV Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential

95%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

88%

ABBV Street Sentiment

ABBV Street Sentiment is extremely bullish and have positive views on the near-term outlook

ABBV Risk Level

ABBV has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

ABBV Performance Sentiment

Sentiments overview associated with ABBV events and the stock performance.

95%

3%

Positive

Negative

35 out of 37
events present

1 out of 37
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Login to display

Support
Price

$223.32

Resistance
Price

$215.62

Current Price Range

$236.28

Show methods +

ABBV Stock IQ

Login to unlock AbbVie (ABBV) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

ABBV Latest Analysis

AbbVie Slipped Below 50-Day SMA Last Week: How to Play the Stock. AbbVie dips below its 50-day SMA but strong immunology momentum and a resilient long-term trend keep the story compelling.

Fri Dec 12, 2025

$223.32 | -0.29%

Momentum

Potential

Leading Multiple Myeloma Results Unveiled at ASH 2025: Paradigm-Shifting Data Redefines Treatment Landscape | DelveInsight. ASH Annual Meeting and Exposition leaves the oncology community buzzing over a series of late-breaking presentations that experts are calling unprecedented. Major pharmaceutical developers such as Johnson & Johnson Arcellx Gilead Bristol Myers Squibb Regeneron AbbVie CellCentric...

Thu Dec 11, 2025

$223.98 | -0.53%

Activity

Is AbbVie Stock Too Cheap to Ignore at Todays Price?.

Thu Dec 11, 2025

$223.98 | -0.53%

Potential

DISCO Pharmaceuticals Appoints Mark Manfredi as CEO and Announces Final Close of €36 Million Seed Financing. Mark Manfredi brings over two decades of international biopharmaceutical industry leadership and cancer drug discovery success to DISCOFinancing will support the development of novel surfaceome-targeted therapies for hard-to-treat tumorsCologne Germany December 11 2025 – (DISCO) today announced the appointment of seasoned biotech leader Mark Manfredi Ph.D. as Chief Executive Officer (CEO

Thu Dec 11, 2025

$223.98 | -0.53%

Activity

HSBC Upgrades AbbVie (ABBV) to Buy Raises Price Target to $265. AbbVie Inc. (NYSE:ABBV) is included among the 15 Best Stocks to Buy for the Long Term. On December 10 HSBC increased its price target on AbbVie Inc. (NYSE:ABBV) from $225 to $265 and also upgraded the stock to Buy. Previously on November 5 Piper Sandler reiterated a Buy rating on ABBV with a $289 price [….]

Thu Dec 11, 2025

$223.98 | -0.53%

Activity

Potential

Rating

HSBC Upgrades AbbVie (ABBV). Fintel reports that on December 10 2025 HSBC upgraded their outlook for AbbVie (NYSE:ABBV) from Hold to Buy. Analyst Price Forecast Suggests 11.48% Upside

Wed Dec 10, 2025

$225.18 | +0.98%

Potential

Rating

This AbbVie Analyst Turns ish. Here Are Top 5 Upgrades For Wednesday. Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes including upgrades downgrades and initiations please see our analyst ratings page.BMO Capital analyst Benjamin Mayhew upgraded ) from Market Perform to Outperform and raised the price target from $50 to $65. Andersons shares closed at $49.36 on Tuesday. See how other analysts view this stock.HSBC analyst Rajesh

Wed Dec 10, 2025

$225.18 | +0.98%

Potential

Rating

3 Top Dividend Stocks to Buy in December. Key PointsAbbVie is a Dividend King that has proven its resilience.

Tue Dec 9, 2025

$222.99 | -0.03%

Potential

OSE Immunotherapeutics Announces Strategic Amendment to AbbVies Partnership on ABBV-230 Development. OSE Immunotherapeutics Announces Strategic Amendment to AbbVie'.s Partnership on ABBV-230 Development Strategic Amendment Enhances OSE Immunotherapeutics'. Role in ABBV-230 Development While Preserving AbbVie'.s Long-Term CommitmentNANTES France December 8th 2025 – 7:30am CET - OSE Immunotherapeutics SA (SGMX: Mnemo: OSE)) today announced an amendment to its partnership agreement with

Mon Dec 8, 2025

$223.12 | -1.31%

Activity

How Strong Is AbbVies Immunology Franchise After Humiras LOE?. ABBV rebounds after Humiras LOE as soaring Skyrizi and Rinvoq sales drive a powerful immunology comeback.

Thu Dec 4, 2025

$228.71 | -0.60%

Momentum

Discover ABBV Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of ABBV. We're here to help you make informed investment decisions today.

FIND US ON

Receive our ABBV Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

ABBV Stock trends

ABBV Stock performance

ABBV Stock analysis

ABBV investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing ABBV

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing ABBV

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

ABBV Stock Analysis & IQ Rating | AbbVie

ABBV Stock IQ

ABBV Target Price

ABBV Risk Level

ABBV Analysts Opinion

ABBV Street Sentiment

ABBV Performance Sentiment

Technical Price Levels

Explore our ABBV Stock insights

Receive our ABBV Daily Alerts

ABBV Street Sentiment

ABBV Risk Level

Technical Price Levels

Discover ABBV Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of ABBV. We're here to help you make informed investment decisions today.

Receive our ABBV Daily Alerts

ABBV Runner Alarm